The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: FTSE closing in on record high as commodity stocks rally

Fri, 13th Feb 2015 16:30

UK stocks jumped on Friday as rising commodity prices lifted shares in the oil and mining sectors, while hopes increased that Europe can come to an agreement over the future of Greece.The FTSE 100 rose 0.7% to 6,873.52 by the end of trade, its best finish since early September 2014. The index is now within touching distance of the closing high of 6,930 in December 1999.Oil stocks were performing particularly well as the price of Brent crude topped the $60-a-barrel mark for the first time this year, while miners tracked metal prices higher.Germany's DAX benchmark index rose to an intraday high of 11,014, its first time above 11,000, after data showed the German economic growth accelerated strongly to 0.7% in the fourth quarter of 2014 from 0.1% the preceding three months. As such, gross domestic product (GDP) growth across the wider Eurozone unexpectedly picked up to 0.3% from 0.2% in the third quarter.Over in Greece, the new government promised to do "whatever we can" to secure a deal with its international creditors next week. Greece and its creditors began technical talks on Friday to lay the ground for a deal on the country's bailout ahead of Monday's meeting of Eurozone finance ministers.Concerns about the Ukraine crisis have also eased after the country agreed to a ceasefire with Russia after tense negotiations in Minsk. However, there was continued fighting overnight in the rebel-held cities of eastern Ukraine, with the ceasefire not expected to kick in until Sunday.Oil and mining stocks jumpOil companies such as Tullow Oil, BG Group, Shell and BP were all performing well on the back of hopes that crude prices may have finally reached a bottom after a torrid few months for the industry.Afren erased earlier losses to push higher despite the news that it has terminated talks about a potential takeover from Seplat. However, the board did say that it was talking with new third-party investors about recapitalising the company, which is struggling with funding.Miners were also in demand, including BHP Billiton, Rio Tinto, Glencore and Antofagasta, as gold, silver and copper prices improved.Anglo American also advanced despite the news that it has decided to write-down the value of certain assets by $3.9bn on the back of weaker iron ore prices, pushing the company into the red for the 2014 financial year. Even Fresnillo gained despite explaining how foreign exchange movements, depreciation and write-downs would adversely affect the silver producer's 2014 results.Glaxosmithkline's shares were given a boost by UBS which upgraded its rating for the pharmaceutical stock by two notches from 'sell' to 'buy', saying that the business is now at an "inflection point" after a tough few years. The bank hiked its target price for the stock from 1,250p to 1,700p,Rolls-Royce also rose, turning around after an earlier fall, as the engine maker met forecasts with its 2014 results and 2015 guidance. The group reported an 8% decline in underlying pre-tax profit to £1.76bn last year.Among the notable fallers was utilities group Severn Trent after saying that while it is on track to hit expectations this financial year, operating costs are expected to rise.Meanwhile, Bwin.Party plummeted 18% after reports emerged that potential suitors are rumoured to have lost interest in acquiring the betting group. Market MoverstechMARK 3,128.03 +0.38%FTSE 100 6,873.52 +0.67%FTSE 250 16,847.78 +0.23%FTSE 100 - RisersTullow Oil (TLW) 405.00p +5.17%BHP Billiton (BLT) 1,569.00p +4.98%GlaxoSmithKline (GSK) 1,553.00p +4.54%Rolls-Royce Holdings (RR.) 944.50p +4.36%BG Group (BG.) 974.80p +4.32%Rio Tinto (RIO) 3,151.50p +3.68%Antofagasta (ANTO) 731.00p +3.61%Glencore (GLEN) 286.60p +3.50%Anglo American (AAL) 1,204.50p +3.35%Standard Chartered (STAN) 956.40p +3.23%FTSE 100 - FallersAshtead Group (AHT) 1,073.00p -2.45%BT Group (BT.A) 439.10p -2.42%Carnival (CCL) 2,900.00p -2.13%ARM Holdings (ARM) 1,062.00p -2.12%Associated British Foods (ABF) 2,905.00p -2.06%easyJet (EZJ) 1,707.00p -2.01%SSE (SSE) 1,568.00p -2.00%United Utilities Group (UU.) 954.00p -1.95%Taylor Wimpey (TW.) 140.50p -1.89%Severn Trent (SVT) 2,019.00p -1.85%FTSE 250 - RisersVedanta Resources (VED) 524.00p +10.78%RPS Group (RPS) 248.40p +9.48%Premier Oil (PMO) 173.10p +8.94%Spire Healthcare Group (SPI) 316.90p +4.86%Kaz Minerals (KAZ) 257.70p +4.63%Hellermanntyton Group (HTY) 329.00p +4.35%Lonmin (LMI) 163.30p +4.01%Countrywide (CWD) 539.50p +3.95%Atkins (WS) (ATK) 1,361.00p +3.50%Drax Group (DRX) 422.10p +3.18%FTSE 250 - FallersBwin.party Digital Entertainment (BPTY) 83.55p -18.49%Supergroup (SGP) 1,002.00p -5.38%AO World (AO.) 290.00p -4.79%Acacia Mining (ACA) 270.20p -3.88%Alent (ALNT) 337.50p -3.57%Nostrum Oil & Gas (NOG) 493.60p -3.03%Rank Group (RNK) 181.50p -2.94%Spirax-Sarco Engineering (SPX) 3,117.00p -2.78%Crest Nicholson Holdings (CRST) 443.40p -2.49%Indivior (INDV) 166.40p -2.46%
More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.